Identification
- Composition (DCI)
- sunitinib
- Manufacturer
- PROMOPHARM (HIKMA)
- ATC code
- L01XE04
- Presentation
- Boite de 30
- Schedule / Reimb.
- A
- Hospital price
- 19066.00 MAD
Indications
Traitement de patients atteints de carcinome rénal avancé et/ou métastatique (RCC). Traitement de patients atteints de tumeurs stromales gastro-intestinales malignes (GIST) en cas de résistance ou d'intolérance à l'imatinib. Traitement de patients atteints de carcinome neuro-endocrine du pancréas, non résécable, bien différencié, avancé et/ou métastatique (pancreatic NET).
Find an open pharmacy
On-call pharmacies near you
About SOVIDEX 50 MG
SOVIDEX 50 MG is marketed in Morocco by PROMOPHARM (HIKMA) and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of SOVIDEX 50 MG, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about SOVIDEX 50 MG
Answers to common questions from Moroccan patients about this drug.